Inventor · disambiguated record
Aram Oganesian
Also filed as: OGANESIAN ARAM
4 granted patents·5 pending applications·0 citations·filing 2019–2025
58Inventor score
Technology areasA61K
Top patents by PatentIndex Score
9 records- 0179US11963971B2Combination decitabine and cedazuridine solid oral dosage formsOTSUKA PHARMA CO LTD·Filed 2023·Granted Apr 23, 2024·0 cites·9 claims
- 0270US11660310B2Low dose combination CDA substrate drug/cedazuridine with extended administrationOTSUKA PHARMA CO LTD·Filed 2021·Granted May 30, 2023·0 cites·19 claims
- 0370US2023270771A1Low dose combination cda substrate drug/cedazuridine with extended administrationOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0469US12239653B2Combination decitabine and cedazuridine solid oral dosage formsTAIHO PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 4, 2025·0 cites·10 claims
- 0569US11224610B2Low dose combination CDA substrate drug/cedazuridine with extended administrationOTSUKA PHARMA CO LTD·Filed 2019·Granted Jan 18, 2022·0 cites·10 claims
- 0666US2025177427A1Combination decitabine and cedazuridine solid oral dosage formsTAIHO PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0760US2024082286A1Combination therapies for treatment of t-cell lymphomasOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0853US2023338342A1Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inhibitorTAIHO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0947US2023405037A1Pharmaceutical compositions and methods of using the same for treating cancerOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →